Drug target identification from protein dynamics using quantitative pathway analysis

Journal of Proteome Research

Volumn 10, Issue 5, 2011, Pages 2679-2683

  Good, David M ^a   Zubarev, Roman A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

AUTHOR; KEYWORDS; PLEASE; PROVIDE

Indexed keywords

CAMPTOTHECIN;

ARTICLE; DRUG TARGETING; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS;

CAMPTOTHECIN; DRUG DELIVERY SYSTEMS; FLUORESCENCE; PROTEINS; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 79955821295     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200090m     Document Type: Article

References (14)

1. Liu, H.; Chang, D. W.; Yang, X. Interdimer processing and linearity of procaspase-3 activation. A unifying mechanism for the activation of initiator and effector caspases J. Biol. Chem. 2005, 280 (12) 11578-82 (Pubitemid 40418470)
2. Chang, D. W.; Xing, Z.; Pan, Y.; Algeciras-Schimnich, A.; Barnhart, B. C.; Yaish-Ohad, S.; Peter, M. E.; Yang, X. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis EMBO J. 2002, 21 (14) 3704-14 (Pubitemid 34787044)
3. Irmler, M.; Thome, M.; Hahne, M.; Schneider, P.; Hofmann, K.; Steiner, V.; Bodmer, J. L.; Schroter, M.; Burns, K.; Mattmann, C.; Rimoldi, D.; French, L. E.; Tschopp, J. Inhibition of death receptor signals by cellular FLIP Nature 1997, 388 (6638) 190-5 (Pubitemid 27297457)
4. Tschopp, J.; Irmler, M.; Thome, M. Inhibition of fas death signals by FLIPs Curr. Opin. Immunol. 1998, 10 (5) 552-8 (Pubitemid 28479188)
5. Barila, D.; Rufini, A.; Condo, I.; Ventura, N.; Dorey, K.; Superti-Furga, G.; Testi, R. Caspase-dependent cleavage of c-Abl contributes to apoptosis Mol. Cell. Biol. 2003, 23 (8) 2790-9 (Pubitemid 36403078)
6. Yu, D.; Khan, E.; Khaleque, M. A.; Lee, J.; Laco, G.; Kohlhagen, G.; Kharbanda, S.; Cheng, Y. C.; Pommier, Y.; Bharti, A. Phosphorylation of DNA topoisomerase I by the c-Abl tyrosine kinase confers camptothecin sensitivity J. Biol. Chem. 2004, 279 (50) 51851-61 (Pubitemid 39656552)
7. Yokoyama, K.; Erickson, H. P.; Ikeda, Y.; Takada, Y. Identification of amino acid sequences in fibrinogen gamma -chain and tenascin C C-terminal domains critical for binding to integrin alpha vbeta 3 J. Biol. Chem. 2000, 275 (22) 16891-8 (Pubitemid 30398926)
8. Arias-Salgado, E. G.; Lizano, S.; Sarkar, S.; Brugge, J. S.; Ginsberg, M. H.; Shattil, S. J. Src kinase activation by direct interaction with the integrin beta cytoplasmic domain Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (23) 13298-302 (Pubitemid 37444736)
9. Plattner, R.; Kadlec, L.; DeMali, K. A.; Kazlauskas, A.; Pendergast, A. M. c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF Genes Dev. 1999, 13 (18) 2400-11 (Pubitemid 29453611)
10. Paul, S. M.; Mytelka, D. S.; Dunwiddie, C. T.; Persinger, C. C.; Munos, B. H.; Lindborg, S. R.; Schacht, A. L. How to improve R&D productivity: the pharmaceutical industry's grand challenge Nat. Rev. Drug Discovery 2010, 9 (3) 203-14
11. Mathieu, M. P. Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2008/2009; Parexel International Corporation: Waltham, MA, 2008.
12. Cohen, A. A.; Geva-Zatorsky, N.; Eden, E.; Frenkel-Morgenstern, M.; Issaeva, I.; Sigal, A.; Milo, R.; Cohen-Saidon, C.; Liron, Y.; Kam, Z.; Cohen, L.; Danon, T.; Perzov, N.; Alon, U. Dynamic Proteomics of Individual Cancer Cells in Response to a Drug Science 2008, 322 (5907) 1511-1516
13. Jarvik, J. W.; Adler, S. A.; Telmer, C. A.; Subramaniam, V.; Lopez, A. J. CD-tagging: A new approach to gene and protein discovery and analysis Biotechniques 1996, 20 (5) 896
14. Zubarev, R. A.; Nielsen, M. L.; Fung, E. M.; Savitski, M. M.; Kel-Margoulis, O.; Wingender, E.; Kel, A. Identification of dominant signaling pathways from proteomics expression data J. Proteomics 2008, 71 (1) 89-96 (Pubitemid 351711646)